Document Detail

Infusion of purified antithrombin III to patients with fracture of the neck of the femur.
MedLine Citation:
PMID:  527616     Owner:  NLM     Status:  MEDLINE    
A purified antithrombin III (AT) preparation was infused in 8 patients with hip fractures, while 8 patients were observed as controls. The infusion was well tolerated by all patients, and the AT activity in plasma was significantly raised throughout an observation period of 48 h as compared with the controls.
G Medén-Britth; A N Teien
Related Documents :
20224256 - Anti-heparin/pf4 complexes by elisa in patients with disseminated intravascular coagula...
9184386 - High prevalence of elevated factor viii levels in patients referred for thrombophilia s...
16678686 - Activated protein c-protein c inhibitor complex: a new biological marker for aortic ane...
8580566 - Acquired factor viii-specific antibody disorder accompanied by a life-threatening retro...
11953626 - Hypofibrinolysis, lipoprotein(a), and plasminogen activator inhibitor.
3345876 - Clinicopathological features of nonsteroidal antiinflammatory drug-induced small intest...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European surgical research. Europäische chirurgische Forschung. Recherches chirurgicales européennes     Volume:  11     ISSN:  0014-312X     ISO Abbreviation:  Eur Surg Res     Publication Date:  1979  
Date Detail:
Created Date:  1980-04-25     Completed Date:  1980-04-25     Revised Date:  2006-11-30    
Medline Journal Info:
Nlm Unique ID:  0174752     Medline TA:  Eur Surg Res     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  289-95     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antithrombin III / administration & dosage,  analysis,  therapeutic use*
Femoral Neck Fractures / surgery*
Hip Fractures / surgery*
Infusions, Parenteral
Middle Aged
Postoperative Complications / prevention & control*
Thrombophlebitis / etiology,  prevention & control*
Reg. No./Substance:
9000-94-6/Antithrombin III

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The effect of dextran on the platelet distribution and lysability of ex vivo thrombi in dogs.
Next Document:  Circulating tissue thromboplastin during hip surgery.